In this cohort study, we ascertained baseline biomarkers of selenoprotein P in cerebrospinal fluid and blood of subjects with mild cognitive impairment (MCI) and assessed the extent to which these biomarkers were related to subsequent progression to dementia. This evidence concerns the gene SELENOP and Cognitive impairment.